Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-Hydroxy-Beta-Methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: a Controlled Trial

NCT03892070 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT03892070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03892070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-Hydroxy-Beta-Methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: a Controlled Trial
Lead sponsor
University of Roma La Sapienza
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2019
Completion date
September 10, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, sarcopenia